Dose-finding Study for AdimrSC-2f Vaccine
Clinical trial NCT05104489 · COMPLETED
Trial details
- NCT number
- NCT05104489
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-03
- Primary completion
- 2022-12-29
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.